The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-EPOCH) ± rituximab (R) + tafasitamab (tafa) in adults with newly diagnosed (ND) Philadelphia chromosome–negative (Ph-) B lymphoblastic leukemia (B-ALL).
 
Noam Kopmar
No Relationships to Disclose
 
Jonathan Fromm
No Relationships to Disclose
 
Noah Pinke
No Relationships to Disclose
 
Ted Gooley
Consulting or Advisory Role - Regimmune
 
Christen Martino
No Relationships to Disclose
 
Ashtyn Sherrow
No Relationships to Disclose
 
Cristina Ghiuzeli
Employment - Fred Hutchinson Cancer Center; University of Washington
Stock and Other Ownership Interests - Axsome Therapeutics; Bristol Myers Squibb Foundation; crispr therapeutics; Intellia Therapeutics; Ionis Pharmaceuticals; Johnson & Johnson/Janssen; Pfizer; Repare Therapeutics; Sanofi; Syndax; TG Therapeutics; Uniqure; Vertex
 
Jason Cooper
No Relationships to Disclose
 
Erik Kimble
Research Funding - Juno/Bristol-Myers Sqibb; ScaleReady, LLC
Patents, Royalties, Other Intellectual Property - Beneficiary of licensing agreements with Cell Signaling Technology; Inventor on patents related to CAR T-cell therapy.
 
Johnnie Orozco
No Relationships to Disclose
 
Mary-Elizabeth Percival
Consulting or Advisory Role - Genentech
Research Funding - Abbvie (Inst); Ascentage Pharma (Inst); Astex Pharmaceuticals (Inst); Biosight (Inst); Cardiff Biotechnology (Inst); Celgene/Bristol-Myers Squibb (Inst); Glycomimetics (Inst); Immunogen (Inst); Oscotec (Inst); Pfizer (Inst); Telios (Inst)
 
Roland Walter
Consulting or Advisory Role - Abbvie; Adicet Bio; BerGenBio; Bristol-Myers Squibb/Celgene/Juno; GlaxoSmithKline; Kura Oncology; Orum Therapeutics; WUGEN, Inc.
Research Funding - Amgen (Inst); Aptevo Therapeutics (Inst); Immunogen (Inst); Janssen Research & Development (Inst); Jazz Pharmaceuticals (Inst); Kite/Gilead; Kura Oncology (Inst); Macrogenics (Inst); Pfizer; Vor Biopharma (Inst)
 
Anna Halpern
Honoraria - Curio Science
Consulting or Advisory Role - Abbvie; Karyopharm Therapeutics; Notable labs
Research Funding - Bayer (Inst); Chordia Therapeutics (Inst); disc medicine (Inst); Gilead/Forty Seven (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Pharmaessentia (Inst); Protagonist Therapeutics (Inst); Sumitomo Pharma Oncology (Inst)
 
Paul Hendrie
No Relationships to Disclose
 
Raya Mawad
No Relationships to Disclose
 
Vivian Oehler
No Relationships to Disclose
 
Bart Scott
Honoraria - Alexion Pharmaceuticals; Alexion Pharmaceuticals; Bristol-Myers Squibb; Incyte; Novartis; Taiho Oncology
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Celgene; Geron; Novartis
Speakers' Bureau - Alexion Pharmaceuticals; Celgene; Jazz Pharmaceuticals; Novartis
Research Funding - Celgene (Inst); Kartos Therapeutics
 
Joshua Veatch
Stock and Other Ownership Interests - Novo Nordisk
Consulting or Advisory Role - Hox Bio
Research Funding - Gilead Sciences
Patents, Royalties, Other Intellectual Property - There are 3 patents on which I am an inventor that have been licensed
 
Ryan Cassaday
Honoraria - AstraZeneca; Autolus Therapeutics; Clear Pharmaceuticals; Pfizer; Takeda
Consulting or Advisory Role - Merck; Sana Biotechnology; SERVIER
Research Funding - Amgen (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Pfizer; SERVIER (Inst)
Other Relationship - Autolus; Pepromene